MDCorp (MDCX) P/E (2024 - 2026)
MDCorp (MDCX) P/E from Nov 14, 2024 to Jun 3, 2026. The TTM MDCorp (MDCX) P/E is -0.28. You can export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
P/E
Annual P/E change of MDCorp (MDCX)
| Year | P/E | Change |
|---|---|---|
| 2026 | -0.28 | -75.61% |
| 2025 | -1.13 | -42.02% |
| 2024 | -1.95 | N/A |
Comparison MDCorp (MDCX) P/E with competitors
MDCorp (MDCX) P/E is -0.28.
| Ticker | Name | P/E | Upside |
|---|---|---|---|
| NVO | Novo Nordisk | 10.39 | -3858.15% |
| GRFS | Grifols SA | 11.29 | -4182.86% |
| GSK | GSK Plc | 12.14 | -4490.11% |
| PFE | Pfizer Inc | 12.31 | -4551.56% |
| SNY | Sanofi | 12.33 | -4560.93% |
| BMY | Bristol-Myers Squibb Company | 13.54 | -4999.15% |
| OGN | Organon & Company | 14.21 | -5240.12% |
| BIIB | Biogen Inc | 17.38 | -6387.30% |
| GILD | Gilead Sciences Inc | 18.01 | -6615.73% |
| JNJ | Johnson & Johnson | 20.68 | -7581.51% |
| NVS | Novartis AG | 21.64 | -7928.61% |
| AMGN | AMGEN Inc | 23.21 | -8496.76% |
| MRK | Merck & Co Inc | 27.45 | -10029.27% |
| AZN | Astrazeneca plc | 27.89 | -10189.48% |
| LLY | Lilly(Eli) & Company | 45.43 | -16532.09% |
| ABBV | Abbvie Inc | 122.69 | -44479.06% |